These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23807694)

  • 1. A competing risks approach for nonparametric estimation of transition probabilities in a non-Markov illness-death model.
    Allignol A; Beyersmann J; Gerds T; Latouche A
    Lifetime Data Anal; 2014 Oct; 20(4):495-513. PubMed ID: 23807694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonparametric estimation of transition probabilities in the non-Markov illness-death model: A comparative study.
    de Uña-Álvarez J; Meira-Machado L
    Biometrics; 2015 Jun; 71(2):364-75. PubMed ID: 25735883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The competing risks illness-death model under cross-sectional sampling.
    Mandel M
    Biostatistics; 2010 Apr; 11(2):290-303. PubMed ID: 19933879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition probability estimates for non-Markov multi-state models.
    Titman AC
    Biometrics; 2015 Dec; 71(4):1034-41. PubMed ID: 26148652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonparametric estimation of transition probabilities in a non-Markov illness-death model.
    Meira-Machado L; de Uña-Alvarez J; Cadarso-Suárez C
    Lifetime Data Anal; 2006 Sep; 12(3):325-44. PubMed ID: 16917736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-parametric estimation of transition probabilities in non-Markov multi-state models: The landmark Aalen-Johansen estimator.
    Putter H; Spitoni C
    Stat Methods Med Res; 2018 Jul; 27(7):2081-2092. PubMed ID: 29846146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic parametric analysis for a multi-state model in hospital epidemiology.
    von Cube M; Schumacher M; Wolkewitz M
    BMC Med Res Methodol; 2017 Jul; 17(1):111. PubMed ID: 28728582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-cohort approach for multi-state models in hospital epidemiology.
    von Cube M; Schumacher M; Palomar-Martinez M; Olaechea-Astigarraga P; Alvarez-Lerma F; Wolkewitz M
    Stat Med; 2017 Feb; 36(3):481-495. PubMed ID: 27774627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A wild bootstrap approach for the Aalen-Johansen estimator.
    Bluhmki T; Schmoor C; Dobler D; Pauly M; Finke J; Schumacher M; Beyersmann J
    Biometrics; 2018 Sep; 74(3):977-985. PubMed ID: 29451947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stochastic model to measure patient effects stemming from hospital-acquired infections.
    Kastner GT; Shachtman RH
    Oper Res; 1982; 30(6):1105-33. PubMed ID: 10309962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.
    He VY; Condon JR; Baade PD; Zhang X; Zhao Y
    Popul Health Metr; 2017 Jan; 15(1):1. PubMed ID: 28095862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neyman, Markov processes and survival analysis.
    Yang G
    Lifetime Data Anal; 2013 Jul; 19(3):393-411. PubMed ID: 23456282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating hospital heterogeneity with a multi-state frailty model: application to nosocomial pneumonia disease in intensive care units.
    Liquet B; Timsit JF; Rondeau V
    BMC Med Res Methodol; 2012 Jun; 12():79. PubMed ID: 22702430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach.
    Beuscart JB; Pagniez D; Boulanger E; Lessore de Sainte Foy C; Salleron J; Frimat L; Duhamel A
    BMC Nephrol; 2012 May; 13():31. PubMed ID: 22646159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonparametric estimation with recurrent competing risks data.
    Taylor LL; Peña EA
    Lifetime Data Anal; 2014 Oct; 20(4):514-37. PubMed ID: 24072583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the flexible parametric survival model and Cox model in estimating Markov transition probabilities using real-world data.
    Du X; Li M; Zhu P; Wang J; Hou L; Li J; Meng H; Zhou M; Zhu C
    PLoS One; 2018; 13(8):e0200807. PubMed ID: 30133454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival probabilities with time-dependent treatment indicator: quantities and non-parametric estimators.
    Bernasconi DP; Rebora P; Iacobelli S; Valsecchi MG; Antolini L
    Stat Med; 2016 Mar; 35(7):1032-48. PubMed ID: 26503800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxing the assumption of constant transition rates in a multi-state model in hospital epidemiology.
    Hill M; Lambert PC; Crowther MJ
    BMC Med Res Methodol; 2021 Jan; 21(1):16. PubMed ID: 33430778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nonparametric test for Markovianity in the illness-death model.
    Rodríguez-Girondo M; de Uña-Álvarez J
    Stat Med; 2012 Dec; 31(30):4416-27. PubMed ID: 22975898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.